This proposal implies a total equity valuation of approximately EUR 2.6 billion1 for Ablynx and represents a premium of up to 60% over Ablynx's share price
CVS Health (NYSE: CVS), a company at the forefront of changing the health care landscape, and Aetna (NYSE: AET), one of the nation's leading diversified health care benefits companies, today announced the execution of a definitive merger agreement under which CVS Health will acquire all outstanding shares of Aetna for a combination of cash and stock.
Highly Oversubscribed Financing Brings Together Leading Syndicate of Investors to Advance Clinical Development of Novel Cell Therapy for Type 1 Diabetes
Natural Cycles, the first app to be CE-certified as a contraceptive in Europe, raised $30 million in a round led by EQT Ventures. Existing investors Sunstone, E-ventures, and Bonnier Growth Media also participated, bringing the company’s total funding to around $38 million.
Milestone on Bayer’s path to completing the planned acquisition of Monsanto
Medical device maker Teleflex Inc said on Tuesday it would buy privately held NeoTract Inc in its second billion-dollar deal in the past nine months, to strengthen its portfolio of urology devices.